BioLife Solutions Inc (NASDAQ:BLFS) CEO Michael Rice sold 12,540 shares of the firm’s stock in a transaction dated Thursday, February 15th. The shares were sold at an average price of $5.26, for a total transaction of $65,960.40. Following the transaction, the chief executive officer now directly owns 152,057 shares in the company, valued at approximately $799,819.82. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Michael Rice also recently made the following trade(s):
- On Tuesday, January 16th, Michael Rice sold 12,540 shares of BioLife Solutions stock. The shares were sold at an average price of $5.57, for a total transaction of $69,847.80.
BioLife Solutions Inc (NASDAQ BLFS) traded up $0.03 during mid-day trading on Friday, reaching $5.29. 10,729 shares of the company were exchanged, compared to its average volume of 58,129. BioLife Solutions Inc has a one year low of $1.93 and a one year high of $7.53. The firm has a market cap of $72.11, a PE ratio of -12.60 and a beta of 0.32.
Separately, Maxim Group restated a “buy” rating and issued a $7.00 price target on shares of BioLife Solutions in a report on Thursday, October 26th.
A number of hedge funds and other institutional investors have recently made changes to their positions in BLFS. Essex Investment Management Co. LLC acquired a new stake in BioLife Solutions during the 3rd quarter valued at approximately $484,000. Granite Investment Partners LLC acquired a new stake in BioLife Solutions during the 3rd quarter valued at approximately $1,205,000. EAM Investors LLC acquired a new stake in BioLife Solutions during the 3rd quarter valued at approximately $555,000. Wells Fargo & Company MN acquired a new stake in BioLife Solutions during the 4th quarter valued at approximately $111,000. Finally, Millennium Management LLC lifted its stake in BioLife Solutions by 901.6% during the 4th quarter. Millennium Management LLC now owns 182,550 shares of the medical equipment provider’s stock valued at $1,095,000 after acquiring an additional 164,324 shares during the period. Institutional investors and hedge funds own 10.14% of the company’s stock.
TRADEMARK VIOLATION WARNING: “BioLife Solutions Inc (NASDAQ:BLFS) CEO Sells $65,960.40 in Stock” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another site, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this article can be viewed at https://www.dispatchtribunal.com/2018/02/23/michael-rice-sells-12540-shares-of-biolife-solutions-inc-blfs-stock.html.
BioLife Solutions Company Profile
BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.
Receive News & Ratings for BioLife Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions and related companies with MarketBeat.com's FREE daily email newsletter.